Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / BIOTECH ETF
-
Total 13F shares
-
723,453
-
Share change
-
-73,535
-
Total reported value
-
$122,749,533
-
Put/Call ratio
-
120%
-
Price per share
-
$169.68
-
Number of holders
-
109
-
Value change
-
-$11,374,397
-
Number of buys
-
47
-
Number of sells
-
26
Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q4 2020
As of 31 Dec 2020,
VANECK ETF TRUST - BIOTECH ETF (BBH) was held by
109 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
723,453 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MORGAN STANLEY, ROYAL BANK OF CANADA, UBS Group AG, Kestra Advisory Services, LLC, MURPHY CAPITAL MANAGEMENT INC, BANK OF AMERICA CORP /DE/, MOGY JOEL R INVESTMENT COUNSEL INC, CITADEL ADVISORS LLC, and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
110
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.